Clinical Trial

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-16.
Status change: Not Yet Recruiting → Recruiting 2026-06-15
Trial Details
NCT Number NCT06144125
Lead Sponsor Konkuk University Medical Center
Collaborators: Asan Medical Center, Soonchunhyang University Hospital
Conditions Cardiac Valve Disease
Enrollment 100 participants
Start Date 2026-03-27
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-17